M P Girard

Summary

Country: France

Publications

  1. doi request reprint HIV/AIDS vaccines: a need for new concepts?
    Marc P Girard
    Paris 7 Denis Diderot University, Lyon, France
    Int Rev Immunol 27:447-71. 2008
  2. doi request reprint Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010
    Marc P Girard
    French National Academy of Medicine, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 28:6811-20. 2010
  3. doi request reprint Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013
    Marc P Girard
    Unversity Paris Diderot, French National Academy of Medicine, 16 rue Bonaparte, 75006 Paris, France
    Vaccine 31:3766-71. 2013
  4. doi request reprint Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012
    Marc P Girard
    French National Academy of Medicine, 16 rue Bonaparte, 75006 Paris, France
    Vaccine 31:2984-7. 2013
  5. doi request reprint Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012
    Marc P Girard
    French National Academy of Medicine, 16 rue Bonaparte, 75006 Paris, France
    Vaccine 31:2979-83. 2013
  6. ncbi request reprint [HIV/AIDS vaccines: heading for new vaccine approaches?]
    M P Girard
    Università Paris VII Denis Diderot, 39 rue Seignemartin, 69008 Lyon, France
    Bull Soc Pathol Exot 101:220-6. 2008
  7. doi request reprint [Vaccines for the future]
    M P Girard
    Académie nationale de médecine, Universite Paris 7 Denis Diderot, Lyon, France
    Ann Pharm Fr 67:203-12. 2009
  8. doi request reprint The 2009 A (H1N1) influenza virus pandemic: A review
    Marc P Girard
    University Paris 7 Denis Diderot, 39 rue Seignemartin, 69008, Lyon, France
    Vaccine 28:4895-902. 2010
  9. doi request reprint Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review
    Marc P Girard
    University Paris 7, French National Academy of Medicine, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 29:6191-218. 2011
  10. ncbi request reprint [Development of an AIDS vaccine: status report]
    M P Girard
    L Université Paris, 7 Denis Diderot, Lyon, France
    Med Trop (Mars) 67:340-6. 2007

Detail Information

Publications23

  1. doi request reprint HIV/AIDS vaccines: a need for new concepts?
    Marc P Girard
    Paris 7 Denis Diderot University, Lyon, France
    Int Rev Immunol 27:447-71. 2008
    ..As a result, the research community is faced with the daunting task of identifying novel vaccine concepts and products to continue the search. This review highlights and addresses some of the scientific and practical concerns...
  2. doi request reprint Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010
    Marc P Girard
    French National Academy of Medicine, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 28:6811-20. 2010
    ..However, a second dose of vaccine was needed to boost immune responses in infants and toddlers 6 months to 3 years of age and, with some vaccines, in children aged 3-9 years...
  3. doi request reprint Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013
    Marc P Girard
    Unversity Paris Diderot, French National Academy of Medicine, 16 rue Bonaparte, 75006 Paris, France
    Vaccine 31:3766-71. 2013
    ..Other topics that were addressed included an update on clinical trials of pandemic and seasonal influenza vaccines in high-risk groups and vaccine safety, as well as regulatory issues. ..
  4. doi request reprint Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012
    Marc P Girard
    French National Academy of Medicine, 16 rue Bonaparte, 75006 Paris, France
    Vaccine 31:2984-7. 2013
    ....
  5. doi request reprint Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012
    Marc P Girard
    French National Academy of Medicine, 16 rue Bonaparte, 75006 Paris, France
    Vaccine 31:2979-83. 2013
    ..For this reason, innovative approaches are under investigation, including their production in the body through a gene delivery approach, vector immunoprophylaxis...
  6. ncbi request reprint [HIV/AIDS vaccines: heading for new vaccine approaches?]
    M P Girard
    Università Paris VII Denis Diderot, 39 rue Seignemartin, 69008 Lyon, France
    Bull Soc Pathol Exot 101:220-6. 2008
    ....
  7. doi request reprint [Vaccines for the future]
    M P Girard
    Académie nationale de médecine, Universite Paris 7 Denis Diderot, Lyon, France
    Ann Pharm Fr 67:203-12. 2009
    ..This review will focus on examples of preventive vaccines under development that target infectious diseases with a heavy global burden on public health...
  8. doi request reprint The 2009 A (H1N1) influenza virus pandemic: A review
    Marc P Girard
    University Paris 7 Denis Diderot, 39 rue Seignemartin, 69008, Lyon, France
    Vaccine 28:4895-902. 2010
    ..The need for an increased surveillance of influenza virus circulation in swine is outlined...
  9. doi request reprint Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review
    Marc P Girard
    University Paris 7, French National Academy of Medicine, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 29:6191-218. 2011
    ..This article reviews the state of the art of HIV vaccine development and discusses the formidable scientific challenges met in this endeavor, in the context of a better understanding of the immunopathogenesis of the disease...
  10. ncbi request reprint [Development of an AIDS vaccine: status report]
    M P Girard
    L Université Paris, 7 Denis Diderot, Lyon, France
    Med Trop (Mars) 67:340-6. 2007
    ..These vaccines are currently being tested either singly or in various prime-boost combinations using several of these vaccines or DNA vaccines. The efficacy of these vaccination techniques in humans remains to be determined...
  11. ncbi request reprint A review of vaccine research and development: human enteric infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 24:2732-50. 2006
    ..This article reviews the state of the art in vaccine R&D against human viral and bacterial enteric infections of public health importance...
  12. ncbi request reprint A review of vaccine research and development: tuberculosis
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 23:5725-31. 2005
    ..This review summarizes recent advances in tuberculosis vaccine development...
  13. ncbi request reprint A review of vaccine research and development: the human immunodeficiency virus (HIV)
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4062-81. 2006
    ..This article reviews the state of the art in HIV vaccine development, summarizes the results obtained so far and discusses the challenges to be met in the development of the various vaccine candidates...
  14. ncbi request reprint A review of human vaccine research and development: malaria
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 25:1567-80. 2007
    ..This article attempts to summarize the state of the art of malaria vaccine development...
  15. ncbi request reprint A review of vaccine research and development: human acute respiratory infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 23:5708-24. 2005
    ..This article reviews the state of the art in vaccine R&D against ARIs and attempts to address these basic public health questions...
  16. doi request reprint Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007
    Marc P Girard
    Universite Paris 7 Denis Diderot, Paris, France
    Vaccine 26:3969-77. 2008
    ..This report summarizes the main concepts and conclusions that came out of the meeting...
  17. ncbi request reprint A review of vaccine research and development: meningococcal disease
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4692-700. 2006
    ..However, effective global prevention of meningococcal disease will not be achievable without the development of a vaccine against Group B meningitis, for which outer membrane protein vaccines are under development...
  18. doi request reprint Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007
    Marc P Girard
    University Paris Diderot, Lyon, France
    Vaccine 26:2443-50. 2008
  19. ncbi request reprint Support for the RV144 HIV vaccine trial
    Robert Belshe
    Science 305:177-80; author reply 177-80. 2004
  20. ncbi request reprint [The quest for an HIV vaccine]
    Marc P Girard
    Bull Acad Natl Med 189:831-44; discussion 844. 2005
    ..T cell-stimulating vaccines are thus unable to prevent infection but prevent or slow disease progression by controlling virus replication. Their efficacy in humans remains to be determined...
  21. ncbi request reprint Human vaccine research and development: an overview
    Marie Paule Kieny
    Initiative for Vaccine Research, World Health Organization, 20 Avenue Appia, CH1211 Genève27, Switzerland
    Vaccine 23:5705-7. 2005
    ..Importantly, developing countries should be empowered to participate actively in the development and introduction of new vaccines according to their national priorities...
  22. ncbi request reprint Aspects of vaccine development. Introduction
    Marc P Girard
    Comp Immunol Microbiol Infect Dis 31:73-5. 2008
  23. ncbi request reprint More on research in France
    Marc P Girard
    Science 304:1745; author reply 1745. 2004